Cargando…
Avelumab internalization by human circulating immune cells is mediated by both Fc gamma receptor and PD-L1 binding
Avelumab is an IgG1 anti–programmed death ligand 1 (anti–PD-L1) monoclonal antibody that has been approved as a monotherapy for metastatic Merkel cell carcinoma and advanced urothelial carcinoma, and in combination with axitinib for advanced renal cell carcinoma. Avelumab is cleared faster and has a...
Autores principales: | Jin, Hulin, D'Urso, Vittorio, Neuteboom, Berend, McKenna, Sean D., Schweickhardt, Rene, Gross, Alec W., Fomekong Nanfack, Yves, Paoletti, Andrea, Carter, Carina, Toleikis, Lars, Fluck, Markus, Scheuenpflug, Juergen, Cai, Ti |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8409756/ https://www.ncbi.nlm.nih.gov/pubmed/34484871 http://dx.doi.org/10.1080/2162402X.2021.1958590 |
Ejemplares similares
-
Time‐Varying Clearance and Impact of Disease State on the Pharmacokinetics of Avelumab in Merkel Cell Carcinoma and Urothelial Carcinoma
por: Wilkins, Justin J., et al.
Publicado: (2019) -
Changing Body Weight–Based Dosing to a Flat Dose for Avelumab in Metastatic Merkel Cell and Advanced Urothelial Carcinoma
por: Novakovic, Ana M., et al.
Publicado: (2019) -
Inferring Drosophila gap gene regulatory network: a parameter sensitivity and perturbation analysis
por: Fomekong-Nanfack, Yves, et al.
Publicado: (2009) -
Inferring Drosophila gap gene regulatory network: pattern analysis of simulated gene expression profiles and stability analysis
por: Fomekong-Nanfack, Yves, et al.
Publicado: (2009) -
Avelumab in newly diagnosed glioblastoma
por: Jacques, Francois H, et al.
Publicado: (2021)